Table 4.
External validation patient clinical characteristics information.
Variable | External validation (n = 228) |
p |
---|---|---|
Age (years) | < 0.001 | |
<31 | 3 (1.3) | |
31-40 | 5 (2.1) | |
41-50 | 20 (8.6) | |
51-60 | 41 (17.8) | |
61-70 | 72 (31.3) | |
71-80 | 63 (27.3) | |
81-90 | 24 (10.4) | |
>90 | 0 (0.0) | |
T.stage | < 0.001 | |
T1 | 13(5.6) | |
T2 | 12 (5.2) | |
T3 | 173 (75.2) | |
T4a | 23 (10.0) | |
T4b | 7 (3.0) | |
N.stage | < 0.001 | |
N0 | 127 (55.2) | |
N1a | 22 (9.5) | |
N1b | 21 (9.1) | |
N1c | 34 (14.7) | |
N2a | 13 (5.6) | |
N2b | 11 (4.7) | |
M.stage | < 0.001 | |
M0 | 198(86.0) | |
M1a | 14 (6.0) | |
M1b | 16 (6.9) | |
Summary.stage | < 0.001 | |
Localized | 22 (9.5) | |
Regional | 176 (76.5) | |
Distant | 30 (13.0) | |
Chemotherapy | < 0.001 | |
Yes | 97 (42.1) | |
No | 131 (57.9) | |
Liver metastasis | < 0.001 | |
Yes | 3 (1.3) | |
No | 225 (98.7) | |
CEA | < 0.001 | |
Normal | 10,443(59.2) | |
Positive | 7,199(40.8) | |
Survival status | ||
Alive | 12,140(68.8) | |
Dead | 5,502(31.2) |